Information Provided By:
Fly News Breaks for January 6, 2017
MDT
Jan 6, 2017 | 06:50 EDT
Deutsche Bank analyst Kristen Stewart believes shares of Medtronic are oversold at current levels. The stock is down 20% from its July 2016 high of nearly $89 and have returned to the same level at the time of the close of the Covidien deal in early 2015, Stewart tells investors in a research note. She thinks the current valuation provides investors with an attractive entry point. The analyst reiterates a Buy rating on Medtronic with a $96 price target.